testosterone therapy Testosterone Therapy After the FDA Warning Label Change: What the TRAVERSE Trial Actually Found The FDA removed testosterone's cardiovascular boxed warning in 2025, citing the TRAVERSE trial. The same trial found higher rates of atrial fibrillation, kidney injury, and fractures — details the marketing leaves out.
